Toshiba America Medical Systems has debuted four multifrequency transducers to expand its flagship PowerVision ultrasound scanner's pelvic, vascular, and transcranial capabilities. The Tustin, CA-based vendor also released SmartTrace, a spectral Doppler
Toshiba America Medical Systems has debuted four multifrequency transducers to expand its flagship PowerVision ultrasound scanner's pelvic, vascular, and transcranial capabilities. The Tustin, CA-based vendor also released SmartTrace, a spectral Doppler quantification mode for vascular and abdominal studies.
The newest additions to Toshiba's line of probes are two endocavity transducers, a linear-array transducer for peripheral vascular and small-parts exams, and a phased-array sector transducer for transcranial applications. For endocavity imaging, the vendor's PVK-651VT transducer offers an extended 150 field-of-view, which allows physicians to distinguish between intrauterine and ectopic pregnancies, as well as to detect fetal abnormalities, according to the company. The vendor's PVK-720ST transducer, on the other hand, helps physicians to anatomically and hemodynamically evaluate the prostate gland and pelvic cavity with a 120 field-of-view, according to Toshiba.
In vascular and small-parts applications, PLK-503AT supports routine screening and imaging for examining palpable and nonpalpable lesions, including adenomas, fluid collections, and cysts, according to the company. The PSK-20CT phased-array transducer is targeted for the evaluation of intracranial stenosis, occlusions, and several other transcranial applications.
With the company's SmartTrace technique, the Doppler waveform is automatically traced, eliminating the need for manual manipulation, according to the company. The technique, particularly suitable for vascular and abdominal studies, leads to ultrasound exams that are more quantitative, less subjective, and easier to perform, said Suzanne Certain, director of ultrasound marketing.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.